Hereditary Colorectal Cancer Panel
This panel focuses on detecting inherited genetic mutations that increase the risk of colorectal cancers, including Lynch syndrome and familial adenomatous polyposis (FAP). It evaluates 44 genes and is recommended for individuals with a personal or family history of colorectal, endometrial, or gastrointestinal cancers. By identifying pathogenic mutations, this test allows for early intervention strategies […]
Comprehensive Hereditary Cancer Test
The most extensive hereditary cancer panel available, this test analyzes 317 genes associated with a wide array of inherited cancer syndromes. From common cancers like breast, colon, and prostate to rare syndromes affecting the endocrine and nervous systems, this panel offers unmatched genetic coverage. It’s recommended for patients with unclear family histories, multiple cancer diagnoses […]
Hereditary Breast and Ovarian Cancer Panel (BRCA 1&2 inclusive)
This panel is ideal for individuals with a personal or family history of breast and/or ovarian cancer. It examines 50 genes linked to hereditary cancer syndromes, including BRCA1 and BRCA2, and offers comprehensive insight into inherited risks. A simple blood draw unlocks a deeper understanding of genetic predisposition, allowing at-risk individuals and their families to […]
Oncomap90 (Myeloid Panel)
Tailored for hematologic cancers, the Myeloid Neoplasms Focus Panel evaluates 92 genes involved in myeloid disorders such as acute myeloid leukemia (AML), myelodysplastic syndromes (MDS), and myeloproliferative neoplasms (MPNs). It plays a crucial role in diagnosis, prognosis, and treatment selection by identifying mutations that can drive disease progression. The test accepts blood or bone marrow […]
Oncomap130 (Solid Tumor Panel)
The Solid Tumor Panel is a comprehensive test designed to detect genetic alterations in 50 genes that are frequently mutated across a wide range of solid tumors. This includes but is not limited to breast, colorectal, lung, and gastric cancers. By identifying these genetic mutations, the test helps oncologists make informed decisions about targeted therapies […]